Abstract. Constitutive expression of basic fibroblast growth factor (bFGF), a common characteristic of metastatic melanomas, was reproduced in vitro by infection of normal murine melanocytes with a recombinant retrovirus carrying a cDNA for bFGE Expression of bFGF in these cells conferred autonomous growth in culture and extinguished differentiated functions, such as the synthesis of melanin and formation of dendrites. Independence from exogenous bFGF and loss of differentiated functions in vitro were induced also by transformation of melanocytes with the oncogenes myc, E/a, ras, and neu, although bFGF was not expressed by the respective transformants. As shown in skin reconstitution experiments onto syngeneic mice and subcutaneous injections into nude mice, the various transformants differed in their behavior in vivo. The bFGF transformants did not form tumors. They reverted to having a normal, melanotic phenotype and restricted growth. Myc and Ela transformants grew as tumors in nude mice but not in syngeneic, immunocompetent animals. Ras-tmnsformed melanocytes were always tumorigenic, whereas the formation of tumors by neu transformants was suppressed by the concomitant grafting of keratinocytes in reconstituted skin of syngeneic mice. These data show that melanocytes genetically manipulated to produce bFGF acquire properties in vitro similar to those of metastatic melanoma cells or those induced by various oncogenes but that constitutive production of bFGF by itself is insufficient to make melanocytes tumorigenic. The experiments also show that melanocytes transformed by the selected oncogenes respond differentially to various environments in vivo.
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I
NTERACTIONS among cells or tissues are mediated through direct cellular contacts or via the release of dilfusable substances that act over a wide range of distances in minute quantities. An important question concerns the role of such interactions in the control of normal tissue homeostasis and the development of tumors. Skin is an ideal tissue in which to study these interactions, given the unique accessibility of its cells in vivo, in vitro, and upon reconstitution onto the animal.
Keratinocytes and fibroblasts are the major cell types in skin. Melanocytes make up a third population of cutaneous resident cells, with a well-defined course of differentiation and secretory function. They are important in photoprotection and are the cells of origin of one of the most malignant neoplasms, melanoma. Recent advances in the cultivation of melanocytes (Halaban, 1988) have defined the growth characteristics of these cells in vitro and allowed a comparison of some properties of normal melanocytes with those of their transformed counterparts. One of the most significant findings has been that normal melanocytes require exogePlease address correspondence to R. Halaban. nous basic fibroblast growth factor CoFGF) I to proliferate in culture Halaban, 1988) . bFGF substitutes for the phorbol ester 12-0-tetradecanoylphorbol-13-acetate (TPA) used routinely to grow mass cultures of normal melanocytes (Eisinger and Marko, 1982) . In vivo, the requirement for exogenous bFGF appears to be met by basal keratinocytes and possibly dermal fibroblasts (Halaban et al., 1988a) . bFGF is not produced by normal melanocytes but it is made constitutively by metastatic melanoma cells that grow in culture in the absence of added growth factor (Halaban et al., 1988b) . Acquisition of the ability to produce bFGF may, therefore, be one of several transitional steps from a normal melanocyte to a highly malignant melanoma cell that is able to escape environmental control.
In this report, we evaluate the interplay between genetic events and cellular environment in control of melanocyte transformation and tumorigenesis. Murine melanocytes ex-pressing bFGF or one of several activated oncogenes as a result of retroviral infection acquire a similar transformed phenotype in vitro but, as shown by skin reconstitution experiments, the similarities break down in vivo since the variously transformed melanocytes are affected differently by the cutaneous enviroment.
Materials and Methods

Cells
L-BI0.BR melanocytes, established from newborn B10.BR mice (Tamura et al., 1987) , were grown in Ham's F-10 medium (American Biorganics, Inc., N. Tonawanda, NY) supplemented with 48 nM TPA (Chemsyn Science Laboratories, Lenexa, KS), 10% newborn calf serum (Gibco Laboratories, Grand Island, NY), 200 U/ml penicillin, and 100 #g/ml streptomycin (Gibco Laboratories).
Primary keratinocytes were cultured from newborn B10.BR mice as described by Yuspa and Harris (1974) and plated (107 cefls/55-cm 2 dish) in MEM (Gibco Laboratories) at low CaCI2 concentration (0.05 mM) supplemented with 4% Chelex-treated FBS (Flow Laboratories, McLean, VA) and 10 ng/ml epidermal growth factor (Collaborative Research, Bedford, MA) as previously described (Hennings et al., 1980; Dotto et al., 1986 Dotto et al., , 1988 . Keratinocyte cultures were used for grafting 7-10 d after plating. Under these conditions, the primary keratinocyte cultures were free of contaminating fibroblasts but retained some melanocytes, which were carried over at the time of grafting.
Dermal fibroblasts were prepared from newborn BI0.BR mice as described (Dotto et al., 1988) . Cells were plated (2 × 106 celis/55-cm 2 dish) in DME (Gibco Laboratories) supplemented with 10% calf serum (Gibco Laboratories). Cells were grown to confluence (in 1-2 d) and split (1:4) twice before grafting.
Retro~ral Vectors
The MD-bFGF virus was constructed by inserting a complete 1.4-kb cDNA copy of bovine fibroblast growth factor (FGF) (Abraham et ai., 1986) behind the internal SV-40 promoter of the retroviral vector MD at its unique Bgl II site (Fig. 1) . Details of the construction of the MD vector will be presented elsewhere. Briefly, the vector was derived from pC663, a plasmid clone 0retaining the complete genome of myeloproliferntive sarcoma virus (Stocking et al., 1985) . A gene for resistance to 0418 (Southern and Berg, 1982) was inserted at the unique Bam HI site of pC663, while the internal part of the viral genome (from the unique Barn HI to Cla I sites) was replaced with a cassette containing the SV-40 early promoter (Korman et al., 1987) and, behind it, a unique cloning site for either Bgl H/Barn HI or Xho I/Sal I. Psi-2 helper cells (Mann et al., 1983) were transfected with the MD-bFGF recombinant construct, and one clone was selected for production of high-viral titers (measured in terms of G418-resistant colony forming units per milliliter).
The ms-zip 6 and VM-myc retroviruses carry the viral Harvey ms and avian MC29 gag-myc oncogenes, respectively (Dotto et al., 1985) .
The Giu664-neu virus carries a complete cDNA copy of the transforming rat neu oncogene as described by Bargmann and Weinbcrg (1988) . This vi-I'us is able to induce full transformation of established fibroblasts (Bargmann and Weinberg, 1988) and keratinocytes (Dotto et al., 1989) with concomitant high expression of the neu oncoprotein.
The Mp-p53 virus carries a complete cDNA copy of a p53 gene of murine origin (Wolf et ai., 1985) inserted into a derivative of the DOL vector (Korman et al., 1987) where the MuLV long terminal repeat of the vector had been substituted with a long terminal repeat derived from MpSV (Stocking et al., 1985) . Biological activity of this virus was demonstrated in a previous study by transformation of papilloma-derived keratinocytes (Dotto et al., 1989) . MD-p53 is essentially equivalent to Mp-p53 except that it was constructed by insertion of the 1753 cDNA copy into the MD vector at the Bgl II site.
The MD-E/a virus contains a cDNA copy of the 13s transcript of the E/a region Of adenovirus 5 (Roberts et al., 1985) inserted behind the SV-40 promoter of the MD vector, l~igh-titerpsi-2 producer cells (Mann et al., 1983) were used for subsequent studies. Infection of fibroblasts with this virus conferred high expression of the E/a gene product and readily caused morpboiogical transformation of monolayer cultures, inducing a typical cobblestone appearance (Roberts et al., 1985) .
The pC6M-neo virus (Stocking et al., 1985) carries only the 0418 resistance gene with no oncogene and was used as a negative control.
Infection of Melanocytes and Selection of Tmnsformants
Melanocyte cultures, at '~25% confluency in 25-cm 2 flasks, were infected with the various retroviruses by a 2-h exposure to undiluted viral stock with the addition of 8 izg/ml polybrene (Aldrich Chemical Co., Milwaukee, WI). The viral preparations were then removed and replaced with melanocyte medium supplemented with TPA. Infected cultures were grown to confluency (7-10 d) and then split (1:2) into selective media containing 800 ~g/ml (3418 (Gibco Laboratories) with or without TPA.
In Vitro Characterization of Transformed Melanocytes
Growth. Kinetics of cell proliferation with and without G418, with and without TPA, were measured by seeding melanocytes in 12-well plates (~104 cells/cm 2) and counting cells from two wells in a cell counter (Coulter Electronics Inc., Hialeah, FL) at intervals of 2-3 d. Population doubling times were calculated from the slopes of the linear portions of the growth curves.
Mitogenicity. Assays for the mitogenic activity present in cell extracts, described by Halaban et al. (1987) thionine-or cysteine-free DME for 0.5 or 14 h, respectively. Immunoprecipitations with anti-bFGF-(l-24) , anti-p53, and anti-neu antibodies were performed as described (Halaban et ai., 1983) . The PAb421 monoclonal antibodies againstp53 (Harlow et al., 1981) were a gift of Dr. A. Levine (Department of Biology, Princeton University, Princeton, N J). The monoclonal antibody 7.16.4 against the neu gene product (Drebin et al., 1984) was provided by Dr. D. E Stern (Department of Pathology, Yale University, New Haven, CT). Immunoprecipitated proteins were resolved by SDS-PAGE, and dried gels were fluorographed.
lmmunoblotting. Total cell extracts, prepared in electrophoresis sample buffer (5 mM sodium phosphate, pH 7, 2% SDS, 0.1 M DTT, 5% 2-mercaptoethanol, 10% glycerol, 0.4% bromophenol blue) were run on discontinuous 10% acrylamide, 0.13% bisacrylamide gels. The gels were washed for 5 rain in water and once in transfer buffer, and proteins were transferred to nitrocellulose by electrophoresis for 2 h at 50 V in the cold. The transfer buffer and procedures for blocking and washing the filters were as described by Kamps and Sefton (1988) . Blots were incubated with monocfonal antibody Ab-1 against adenovirus E/a gene product (Oncogene Science, Inc., Manbasset, NY) followed by incubation in blocking buffer containing 1/tCi/ml ~25I-protein ,A (ICN Radiocbemicals, Costa Mesa, CA; 35 ttCi/ /tg) and placed on film for autoradiography.
RNA Blotting. 20 ~tg of total cellular RNA was run on an agarose gel and blotted as described by Dotto et al. (1989) . Probes were prepared by gel purification of DNA fragments corresponding to v-Harvey ms and MC29 myc oncogenes (Dotto et al., 1985) and labeled with [32p]dCTP by random oligonucleotide priming as described by Feinbcrg and Vogelstein (1983) .
by a dome-shaped, open-bottom silicon chamber, which provided a barrier to invasion of the graft bed by the surrounding host skin. Cells were then suspended in MEM (Gibco Laboratories) at low calcium concentration (0.05 raM), mixed in various combinations, and injected into the chambers. They readily attached to the underlying granulation tissue and proceeded to form stratified skin in 2-3 wk. The numbers used for injection of each cell type into the chambers were 2 × 105 melanocytes (normal or transformed), 2 × 106 keratinocytes, and 8 × 106 dermal fibroblasts. Mice were killed 21-28 d later, and the graft tissues were fixed for histologic and electron microscopic analysis.
Electron Microscopy
Tissues retrieved from the grafts were immersed in cold aldehyde and sliced vertically to allow embedding in an oriented fashion. Cells in culture were trypsinized, fixed as pellets, and processed like a piece of tissue. Further treatments, including histochemical incubation with DOPA for the localization of tyrosinase, were described elsewhere (Halaban et al., 1988c ; Slominski et al., 1988).
R e s u l t s Transformation of Melanocytes In Vitro by bFGF cDNA
A recombinant retrovirus (MD-bFGF; Fig. 1 ) carrying a complete cDNA copy of bovine bFGF (Abraham et al., 1986) was constructed starting from the retroviral vector MD. Production of a bFGF-like factor by NIH-3T3 cells infected with this virus was verified by a mitogenicity assay with human melanocytes as test cells (Table I) . MD-bFGF was used to infect melanocytes of the L-B10.BR cell line (Tamura et al., 1987) . Although these cells have been passaged in culture for a relatively long time and have lost some of the characteristics of primary melanocytes, such as dependence on external inducers of cAMP, they have retained many other normal properties, including pigment forming ability, TPA and bFGF dependence in culture, and inability to form tumors in animals (our unpublished observations). The chromosome complement of these cells is close to normal, diverging only by inclusion of an isochromosome 6 (Tamura et al., 1987) .
Approximately 10% of L-B10.BR melanocytes from cultures infected with the MD-bFGF virus grew in the presence of G418, and a subfraction acquired the ability to grow in the absence of TPA (Fig. 2) . Independence of the melanocytes from TPA after MD-bFGF infection was associated with loss of melanocyte-specific functions, such as tyrosinase activity, melanogenesis (Table II and Human melanocytes were seeded in PC-I medium plus I mM dibutyryl cAMP in 24-well cluster plates (,~,40,000 cells/W'ell) with and without the various additions.
[3H]Thymidine was incorporated during the last 3 h of a 24-h incubation. Additions were 1 ng/ml bFGF (Collaborative Research, Inc.); extracts from NIH-3T3 and NIH-3T3-bFGFcelIs at 10/~g rni; and L-BI0.BR melanocytes transformed with bFGF cDNA or myc, neu, ras or Ela oncogenes at 50 /~g protein/ml. Values are averages of counts per minute from two wells. Pure bFGF or cell extracts without dibutyryl cAMP were not mitogenic toward human melanocytes ; data not shown). .Q E I0 ~ 8
dendritic cell processes (Fig. 3) . At passage 20, no premelanosomes were found by electron microscopy, and, despite the presence of an elaborate Golgi apparatus, the trans-Golgi reticulum was negative for DOPA oxidase (tyrosinase) activity (Fig. 4) . Extracts of transformed L-B10.BR melanocytes were tested in the mitogenicity bioassay with human melanocytes. Mitogenic activity toward normal melanocytes was present in extracts of MD-bFGF-transformed melanocytes (Table I) but not in extracts prepared from uninfected cells (data not shown) or cells infected with known oncogenes (Table I) . The mitogenic agent was not detectable in the culture medium of MD-bFGF-transformed melanocytes (Table I) as had been shown also for human melanoma cells and normal human keratinocytes, both of which when used as cell extracts were mitogenic toward normal human melanocytes (Halaban et al., 1988a,b) . bFGF in MD-bFGF-transformed melanocytes was demonstrated by immunoprecipitation with anti-bFGF antibodies (Fig. 5) .
L-B10.BR melanocytes infected with the control pC6M-neo virus (Stocking et al., 1985) , which transduces only the G418 resistance gene (Fig. 1) , were able to proliferate in the presence of G418 but remained dependent on TPA for growth (data not shown). No colonies of proliferating cells appeared upon removal of TPA, even after 3 mo of cultivation in the presence of TPA and G418, a time span corresponding approximately to eight population doublings. These melanocytes retained their dendritic shape and their ability to synthesize melanin (Fig. 3) and tyrosinase (Table II) . In the absence of TPA, the cells flattened out in a manner characteristic of growth-arrested melanocytes (Fig. 3) . 
In Vitro Transformation of Melanocytes by Known Oncogenes
Several oncogenes encoding nuclear, cytoplasmic, or mere- 
Tymsinase assays were performed as described by Halaban et al. (1983) with extracts from the various types of melanocytes 1.5-3 mo after selection for growth in the absence of TPA but in the presence of 800 #g/ml G418-sulfate. A unit of tymsinase was defined as the activity of enzyme that catalyzed the oxidation of I t~mol of tyrosine/min. Assays were performed for 10-30 rain.
Melanocytes that lost their pigmentation could not be stimulated m regain it by the addition of TPA and/or isobutylmethyl xanthine. Pigmentation was assessed by the color of the cell pellets (see Fig. 3 ). brahe-bound gene products were introduced into L-B10.BR melanocytes by means of retroviral vector infection (Fig. 1) .
As above, cells were selected for acquisition of G418 resistance and tested for their ability to grow in medium not supplemented with TPA. Of three oncogenes encoding nuclear proteins-the mutated, oncogenic form ofmurinep53 CO¢olf et al., 1985; Finlay et al., 1988) , avian v-myc (Dotto et al., 1985) , and adenovirus E/a (Roberts et al., 1985) -only v-myc and E/a were able to transform melanocytes. L-B10.BR cells infected with either of two p53 recombinant viruses, Mp-p53 or MDp53 (Fig. 1) , remained indistinguishable in phenotype from their uninfected or pC6-neo--infected counterparts (Figs. 2  and 3 ) despite the expression of viral oncoprotein as shown by immunoprecipitation with anti-p53 monoclonal antibody (Fig. 5) .
L-B10.BR melanocytes infected with a retroviral vector carrying the avian MC29 gag-myc oncogene, VM-myc (Dotto et al., 1985) , initially behaved like Mp-or MDp53-infected cells: whereas little or no proliferation occurred in the absence of TPA, many cells acquired the ability to grow in the presence of G418 in permissive (with TPA) medium and remained pigmented and dendritic. After 3-4 wk of TPA starvation, however, colonies of cells appeared that were able to grow in a restrictive (without TPA) medium (Fig. 2) . Like the cells transformed by MD-bFGF, the TPAindependent v-myc transformants were amelanotic, with extremely low tyrosinase activity (Table H and to grow in the absence of TPA correlated with elevated levels of v-myc-RNA expression (Fig. 5) .
L-B10.BR melanocytes were transformed rapidly by infection with a virus carrying a third "nuclear" oncogene, the adenovirus E/a-13s region (Roberts et al., 1985) (MD-E/a; Fig. 1 ). 3-4 d after infection with MD-E/a, the great majority of melanocytes acquired the ability to proliferate equally well whether or not TPA was present (Fig. 2) . Rapid proliferation was accompanied by loss of pigmentation and change in morphology, which, in turn, correlated with a drastic decrease in tyrosinase activity (Table II and Fig. 3 ). MD-E/a-infected L-B10.BR melanocytes expressed high levels of the E/a gene product as shown by immunoblotting with E/a-specific monoelonal antibodies (Fig. 5 ).
Melanocytes infected with viruses carrying the v-Harvey ras or rat neu oncogenes (ms-zip 6 and Glu664-neu; Fig. 1) , encoding, respectively, a cytoplasmic and a plasmalemmal protein (Dotto et al., 1985; Bargmann and Weinberg, 1988) , were transformed with the same rapidity as those infected with the MD-E/a virus and were, like the latter, distinguishable in the phase microscope by their altered morphology within 3-4 d (Fig. 3) . The cells grew rapidly under all culture conditions tested (Fig. 2) and quickly lost their pigmentforming ability (Table II and Fig. 3 ). Oncogene expression in the transformants was verified by RNA blotting (ms) or immunoprecipitation (neu) (Fig. 5) .
The amelanotic ms and neu transformants were examined with the electron microscope at passages 15 and 17, respectively, and were found to contain residual melanosomes. These were segregated in large compartments presumed to be autophagosomes (ms transformants) or they were dispersed singly (neu transformants; Fig. 9 a, insert) . Cultures from both transformants included cells that, on incubation with DOPA, showed evidence of tyrosinase in elements of the trans-Golgi reticulum. Many cells contained DOPApositive lysosome-like granules, similar to the "granular melanosomes" observed in cultures of amelanotic Bomirski hamster melanoma cells after induction of melanogenesis by L-tyrosine (Slominski et al., 1988) .
Tumorigenicity Assay I: Skin Reconstitution Experiments
An important criterion for cell transformation involves assessment of tumorigenic behavior. In previous work with oncogene-transformed keratinocytes, skin reconstitution experiments provided a sensitive tumorigenicity assay of malignant transformation at stages not easily detected by conventional methods (Dotto et al., 1988 (Dotto et al., , 1989 . In addition, and perhaps more importantly, these grafting assays allowed a study of the effects of various cellular permutations under conditions that approximate a normal cutaneous environment (Dotto et al., 1988) .
Grafting experiments onto syngeneic B10.BR mice were performed by use of silicon transplantation chambers into which cultured skin cells were injected in various combinations. Grafting of normal L-B10.BR melanocytes together with primary keratinocytes and dermal fibroblasts resulted, 3-4 wk later, in quasinormal skin, with appropriate reassortment of cells (Fig. 6) . The transferred melanocytes functioned normally (Fig. 7) and were located within or immediately beneath the newly formed epidermis (in cases where only keratinocytes and melanocytes were grafted) or, in addition, admixed with the dermal fibroblasts (when the latter were grafted also). As expected, tumors were not formed by untransformed L-B10.BR melanocytes (Table HI) .
Despite their transformed phenotype in vitro, melanocytes carrying the MD-bFGF virus were not tumorigenic (Table  III) . These highly proliferative, growth factor-independent, amelanotic cells (Figs. 2 and 3 ) behaved after grafting like their parental cell line (Fig. 6 ) and resumed production of pigment (Figs. 4 and 6 ). Reversion to this normal phenotype did not depend on concomitant graRing of fibroblasts and/or epidermal cells (Table HI) .
Similar lack of tumorigenicity was observed after grafting of myc or E/a transformants, both in the presence and absence of keratinocytes and dermal fibroblasts (Table HI) . 2) , two specific bands were detected of which one is likely to correspond to the full-length viral transcript (m6 kb). The other is a small segment that might be a product of internal splicing. The intensity of both bands is markedly higher in the bFGF-independent transformants than in their bFGF-dependent counterparts. In the case of ms-zip6-infected cells (lane 6), two bands were again detected, of which one corresponds to the full-length viral transcript ('~5 kb) and the other represents the endogenous c-Ha-ms transcript ('~1.2 kb), detectable also in the uninfected controls (lanes 4 and 5). Approximate molecular weights were calculated from the migration of ribosomal RNA marker bands (not shown). Figure 6 . Histology of grafts in partially or fully reconstituted syngeneic skin containing control melanocytes or ms or bFGF transformants.
Shown are untransformed L-B10.BR melanocytes grafted with keratinocytes and dermal fibroblasts, ms-transformed melanocytes grafted with aormal keratinocytes, and bFGF transformants grafted as a pure cell population without keratinocytes or dermal fibroblasts. Mice were killed, and tissues were fixed 4 w after grafting. Bar, 23 #m. However, histologic analysis revealed some foci of limited neoplastic proliferation containing a few weakly pigmented cells (Table III and data not shown).
Table IlL Tumor Growth in Reconstituted Skin
Cells M M+K M+F M + K + F L-B10.BR ND 0[0]:3 ND 0[0]:5
L-BIO.BR-bFGF
Melanocytes transformed with ms were tumorigenic. Small, mostly exophytic and unpigmented tumors formed consistently, irrespective of the presence or absence of dermal fibroblasts and/or keratinocytes (Table III) . Spindleshaped and large cuboidal cells infiltrated surrounding tissue. Gray portions of the tumors contained pigmented cells with a foamy appearance, suggesting that these might be macrophages that had ingested melanin (Fig. 6) . Concomitant grafting of keratinocytes resulted in formation of a stratified epidermis on top of the tumors (Fig. 6) . No metastatic spread was detected to liver, lung, or spleen over the duration of the experiments (3-4 wk).
Similar to the ms transformants, neu-transformed melanocytes were able to grow into amelanotic tumors (Fig. 8, top, and Fig. 9 a) when grafted alone or with dermal fibroblasts (Table lII) . Dermal fibroblasts enhanced the growth of these tumors (Table liD. In contrast, when neu-transformed melanocytes were grafted with keratinocytes, tumor formation was drastically suppressed (Fig. 8, bottom; Fig. 9 b; Table  III ). Microscopic foci of neoplastic proliferation were detected in one case only in areas that happened to be devoid of keratinocytes. The presence of dermal fibroblasts enhanced microscopic tumor formation to a limited degree (Table 1II). In all cases, a few differentiated melanocytes were present underneath the newly formed epidermis, some in close apposition to lymphocytes (Fig. 9 b) . These might be phenotypically reverted neu transformants or normal melanocytes carried over with the primary keratinocyte cultures.
Tumorigenicity Assay II: Subcutaneous Injection of Transformants into Nude Mice
The grafting experiments described above made use of syngeneic, immunocompetent mice. To explore a possible role of the immune system in modulating the behavior of the vailmelanosomes, and the small Ones transport vesicles of tyrosinase, visualized with DOPA. N/, nucleus of melanocyte; D, dermis; N2, nucelus of keratinocyte. The arrows indicate basement membrane, and the arrowhead indicates histochemicul DOPA reaction product showing presence of tyrosinase in trans-Golgi reticulum. Bars 1 ~m. ous transformants, tumorigenicity was assayed also by subcutaneous injection of cells into nude mice. Even in this environment, bFGF-transformed melanocytes did not grow as 
L-BiO.BR melanocytes (5 × I0 5, except where specified) transformed with the indicated genes were injected subcutaneously into nude mice. Animals were periodically examined for macroscopic tumors and were killed 60 d after injection. The tumors were fixed in formalin for histological examination. The number of tumors per total number of injections is given as well as the average fresh tumor weight, neu-transformed melanocytes in the indicated numbers were also admixed with fixed numbers of BI0.BR primary keratinocytes (K; 2 x l06) or dermal fibroblasts (F; 8 x l06) before injection. tumors (Table IV) . In two cases, small islands of pigmented cells were found subcutaneously at the presumed site of injection (data not shown). In contrast, rapidly expanding tumors were formed by melanocytes that had been transformed by the myc and E/a oncogenes (Table IV) . No tumors could be detected after subcutaneous injection of these cells into syngeneic mice (data not shown), consistent with the lack of tumorigenicity after grafting ( Table HI) . Melanocytes that had been transformed with the ras and neu oncogenes produced rapidly expanding tumors (Table  IV) . These grew faster in nude mice than in similarly injected syngeneic animals (data not shown). Most of these tumors contained some pigmented regions. Melanocytes transformed with the neu oncogene were also tested for tumorigenicity after having been mixed with keratinocytes and/or dermal fibroblasts (Table IV) . Decreasing numbers of neu transformants were injected together with a constant number of the other cells. Even under conditions where tumors were substantially delayed (by injection of as few as 5 × l0 3 transformants per mouse), no inhibitory effects of added keratinocytes were detected; rather, keratinocytes enhanced the formation of subcutaneous tumors (Table IV) .
Discussion
Melanomas are highly variable with respect to chromosomal aberrations and expression of activated oncogenes, growth factors, growth factor receptors, and cell surface antigens (Houghton et al., 1982; Pathak et al., 1983 ; Dracopoli et al., 1985 Mukai and Dryja, 1986; Real et al., 1986; Westermark et al., 1986; Ellis et al., 1987; Holzmann et al., 1987; Shin et al., 1987; Yamaguchi et al., 1987; Cowan et al., 1988; Adelaide et al., 1988; Linnenbach et al., 1988; Raybaud et al., 1988; Richmond et al., 1988) . In contrast, a characteristic that appears to be common at least to human metastatic melanomas is autonomous growth in vitro, independent of exogenous bFGF and cAMP. This trait appears to be acquired in part through the abnormal expression of bFGF (Halaban et al., 1988b) , the natural growth factor for human melanocytes normally supplied by keratinocytes and possibly fibroblasts (Halaban et al., 1988a) . Because bFGF is not expressed in normal melanocytes (Halaban et al., 1988b) and members of the FGF family are so far the only known natural mitogens for human melanocytes among at least 40 other factors tested (Halaban, 1988) , the aberrant expression of bFGF by metastatic melanomas must represent a critical event in melanocyte transformation, bFGF may have two functions in promoting the development of melanomas: (a) it may play a role in the uncontrolled proliferation of melanocytes by releasing the cells from dependence on neighboring keratinocytes and fibroblasts; and (b) because of its angiogenic properties, it may induce capillary growth required for the sustenance of solid tumors (Folkman, 1985) .
In the experiments described here, independence of melanocyte growth from exogenous bFGF was acquired within days of infection with a bFGF recombinant retrovirus, with concomitant production of biologically active bFGF at levels similar to those observed in human melanomas (Halaban et al., 1988b) . Remarkably, constitutive expression of bFGF was associated with complete loss of differentiated properties and acquisition of a fibroblastoid phenotype, which is also seen in human melanoma cells grown in vitro. Since similar effects are not induced by a continuous supply of exogenous bFGF (our unpublished observations) and all other known mitogens, such as TPA or isobutylmethyl xanthine, stimulate rather than extinguish melanogenesis (Halaban et al., 1983) , it is likely that loss of differentiated phenotype is due to activation of intracellular bFGF receptors by endogenous bFGE This implies that mitogenic stimulation of melanocytes by exogenous growth factor is coupled to a signaling pathway activating genes controlling pigmentation and that continuous stimulation of that pathway is required to maintain melanocyte differentiated functions. Fibroblast transformation by the sis oncogene appears to be mediated through aberrant, intracellular stimulation of the PDGF receptor rather than through receptor stimulation from the outside (Keating and Williams, 1988 ). An analogous mechanism is more difficult to envision with bFGF, a ligand that lacks the signal peptide (Abraham et al., 1986) which would put it in the same subcellular compartment with its receptor. Nevertheless, indirect evidence for the activation of intracellular pools of bFGF receptor by endogenous bFGF was provided in the human melanoma system in which neutralizing antibodies to bFGF as well as anti-phosphotyrosine antibodies-the bFGF receptor is a tyrosine protein kinase (Lee et al., 1989 )-inhibited growth when injected into the cells but not when supplied in the culture medium (Halaban et al., 1988b) .
Aberrant expression of bFGF in vitro, however, is not sufficient to render melanocytes tumorigenic in vivo. In fact, the transformed cells reverted to the untransformed phenotype when placed into the cutaneous environment of host animals. To what extent they continued to express bFGF in this environment is not known. Likewise, the mediators of the phenotypic reversion of bFGF transformants are not known. Since comparable effects were seen in syngeneic and immunodeticient mice, the immune system is unlikely to be involved. Also, keratinocytes or dermal fibroblasts appeared not to be required for reversion of the bFGF transformants when these cells were grafted onto granulation tissue. It is possible that in vivo melanocyte turnover is slowed down and the bFGF produced by the transformants is released into the extracellular matrix and thus stimulates the plasma membrane receptors which then trigger the expression of differentiated functions. Suppression of tumor growth by a developing cutaneous environment has been reported for B16 murine melanoma cells injected into murine embryos (Gerschenson et al., 1986) . In that system, a diffusable melanoma inhibitor was shown to be expressed transiently from gestational ages 10-14 d. The microenvironment in adult organs may also influence pigmentation and tumor growth as observed experimentally with B16 melanoma in mice (Price et al., 1988; Nicolson and Dulski, 1985) and clinically with human metastatic melanomas.
Our results are consistent with those of others who have shown that transfection of fibrohlasts with a cDNA for bFGF can lead to morphological transformation in vitro (Sasada et al., 1988; Neufeld et al., 1988) . Only high expression of transfected bFGF leads to tumorigenicity by fibroblasts (Quarto et al., 1989) . However, when bFGF cDNA is transfected after the addition of a signal sequence, producing a chimeric protein containing a secretory signal peptide at its amino terminus, tumorigenic conversion of fibrohlasts is induced even at low to intermediate levels of expression (Rogelj et al., 1988; Blam et al., 1988) . Tumorigenic conversion of fibroblasts at low levels of growth factor expression has also been obtained with hst/K-FGF, a transforming oncogene from the FGF family which produced a secretory form of bFGF, suggesting that secreted FGF has a higher tumorigenic potential than the cell-associated form, possibly acting through an autocrine control loop (Quarto et al., 1989) .
The results obtained by others with secreted forms of FGF are relevant to the newly discovered bFGF-related oncogenes, all of which contain a signal sequence and are released as diffusible factors (Delli-Bovi et al., 1987 Yoshida et al., 1987; Zhan et al., 1988; Marics et al., 1989) . Two members of this family, hst/K-FGF and int-2, both with chromosomal assignment 11q13, were found to be coamplified in a conjunctival melanoma (one out of eight primary and metastatic melanomas tested; Adelaide et al., 1988) . Because, like bFGF, hst/K-FGF is also a potent mitogen for normal cutaneous melanocytes ), expression of these FGF-like growth factors probably gives growth advantage to a conjunctival melanoma as well.
The bFGF-and TPA-dependent, normally differentiated murine melanocytes were easily transformed to an autonomous mode of growth not only by bFGF cDNA hut also by other oncogenes. Since endogenous bFGF was not induced in any of these oncogene transformants, it appears that transformation to growth factor independence of these melanocytes can be accomplished by several pathways that may converge at a critical but so far unidentified step. The variously transformed melanocytes exhibited differences in morphol-ogy in vitro as well as substantial differences in behavior in vivo in response to a variety of environments. In general, oncogene-transformed melanocytes grew rapidly as tumors when injected subcutaneously into nude mice. However, when tested by subcutaneous injection or by grafting onto syngeneic, immunocompetent mice, only ms-transformed melanocytes were able to form tumors irrespective of their environment.
Neu-transformed melanocytes presented an interesting example of tumor growth modulated by surrounding normal cells. Addition of keratinocytes at the time of grafting was sufficient to inhibit tumor formation in syngeneic animals. In contrast, dermal fibroblasts promoted rather than inhibited growth. Since inhibition by kerntinocytes was not observed in nude mice, it is likely that tumor growth in immunocompetent syngeneic mice was prevented as the result of an interplay between the keratinocytes and the immune system. It is known, for instance, that keratinocytes, which are highly phagocytic cells, display class H histocompatibility antigens in vitro after treatment with interferon (Wikner et al., 1986) , suggesting that keratinocytes could function as antigen-presenting cells. If so, keratinocytes in immunocompetent mice may facilitate immune recognition of neu transformants. This interpretation would be consistent with the close apposition of lymphocytes to residual melanocytes, observed by electron microscopy and by the clinical observation of the slow initial growth of melanomas while still confined to the epidermis.
Carcinoma formation by ms-transformed primary keratinocytes can be suppressed by concomitant grafting of normal dermal fibroblasts (Dotto et al., 1988) . Those results and the results reported here raise the general possibility that heterotypic cell interactions play an important role in regulating tumor development. The underlying mechanisms are likely to be different in the two cases. Since carcinoma inhibition by dermal fibroblasts can be observed also in nude mice, the immune system in this case is unlikely to be involved (Dotto, G. P., unpublished observation) .
Cells transformed by the E/a or myc oncogenes were tumorigenic in nude but not in syngeneic mice irrespective of the presence of normal cutaneous cells, suggesting that the immune system can recognize these transformants and block their growth probably because of the presence of new surface antigens or new combinations of surface antigens. A precedent is the induction of class II histocompatibility antigens in human melanocytes after transformation by the ms oncogene (Albino et al., 1986) . In addition, a number of melanoma-associnted antigens have been described (Herlyn et al., 1987; Houghton et al., 1982; Holzman et al., 1987; Hotta et al., 1988; Yamaguchi et al., 1987) .
The most effective transforming agent in our system was the v-ms oncogene. Work by others has indicated that c-ms activation may have occurred in 10-15 % of human metastatic melanomas (Albino et al., 1984; Sekiya et al., 1984; Padua et al., 1985; Gerhard et al., 1986; Albino, 1988; Raybaud et al., 1988) . Direct transformation of normal human melanocytes by v-ms oncogenes resulted in a partially transformed phenotype, including induction of new surface antigens and ability to grow in soft 'agar (Albino et al., 1986; Albino, 1988) . However, other markers of transformation, such as growth factor independence and loss of pigment forming ability, were not observed, suggesting that transformation of human melanocytes by ms oncogenes alone was not sufficient to induce a fully transformed phenotype (Albino et al., 1986) . Recently, results similar to ours were reported by Wilson et al. (1989) , who showed that transformation of a nontumorigenic line of murine melanocytes with the v-Ha-ms oncogene resulted in tumorigenic conversion (as detected in nude mice) together with growth factor independence and amelanosis in vitro. Extinction of differentiated functions was observed also after transformation of chicken retinal melanocytes with Rous sarcoma virus (Boettiger et al., 1977) , and uveal melanomas were induced by direct injection of feline sarcoma virus into the anterior chamber of the eyes of newborn kittens (Albert et al., 1981) .
